K12 Program Eligibility & Benefits

Program Eligibility | Program Benefits

Program Eligibility

Scholars must have an M.D., D.O., M.D./Ph.D., or D.O./Ph.D., have completed residency/fellowship training or postdoctoral training, and be committed to a career in translational, patient-oriented oncology research with an emphasis on therapeutic trial development. Patient-oriented oncology research is research conducted with human subjects (or on material of human origin such as tissues, specimens, and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects. Excluded from this definition are in vitro studies that utilize human tissues that cannot be linked to a living individual.

Candidates for support as MUSC Hollings Cancer Center K12 Scholars must also:

  • Be a U.S. citizen or non-citizen national, or must have been lawfully admitted for permanent residence or possess an Alien Registration Receipt Card (I-151 or I-155) or some other verification of legal admission as a permanent resident.
  • Be able to commit at least 75% or full-time professional effort in this program and its related clinical research activities for two years.
  • Not be or have been a Principal Investigator on an R01 or a subproject of a Program Project (P01), Center (P50, P60, U54), mentored career development (K-series) grant, or other equivalent research grant awards.

Program Benefits

  • Salary Support: 75% of a Calabresi Scholar’s salary (up to $100,000 per year for a maximum of two years) is provided by the program.
  • Protected Research Time: A minimum of 75% protected time for two years must be guaranteed by each Scholar’s department.
  • Research Funding: Up to $26,000 per year in research development support and tuition is provided to each Scholar annually.*
  • Scientific Meetings: Scholars are provided with $2,000 per year for travel in order to attend national meetings.
  • Master of Science in Clinical Research: Scholars will have the opportunity (optional) to obtain a Master of Science in Clinical Research.

* Hollings Cancer Center supplements the K12 Program with philanthropic funding to support additional scholars.